Warfarin use in nursing home residents: Results from the 2004 national nursing home survey

American Journal Geriatric Pharmacotherapy

Volumn 10, Issue 1, 2012, Pages

  Ghaswalla, Parinaz K ^a   Harpe, Spencer E ^a   Slattum, Patricia W ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

atrial fibrillation; nursing homes; underuse; warfarin

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; TICLOPIDINE; WARFARIN;

ADULT; AGED; BLEEDING; CONGESTIVE HEART FAILURE; CROSS-SECTIONAL STUDY; DATA BASE; DEEP VEIN THROMBOSIS; DRUG USE; EMBOLISM; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NURSING HOME PERSONNEL; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RACE; RESIDENT; REVIEW; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK; VALVULAR HEART DISEASE;

EID: 84857048477     PISSN: 15435946     EISSN: 18767761     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2011.12.001     Document Type: Review

References (69)

1. A.S. Go, E.M. Hylek, K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375 (Pubitemid 32424106)
2. K. Lakshminarayan, D.C. Anderson, C.A. Herzog, A.I. Qureshi Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the united states Neurologist 14 2008 143 150 (Pubitemid 351671254)
3. D.E. Singer, G.W. Albers, J.E. Dalen Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) Chest 133 6 suppl 2008 546S 592S (Pubitemid 351892972)
4. L.B. Goldstein, R. Adams, M.J. Alberts American Heart Association American Stroke Association Stroke Council Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group: Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation 113 2006 e873 e923
5. V. Fuster, L.E. Rydn, D.S. Cannom American College of Cardiology American Heart Association Task Force European Society of Cardiology Committee for Practice Guidelines European Heart Rhythm Association Heart Rhythm Society ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace 8 2006 651 745 (Pubitemid 44472247)
6. R.G. Hart, O. Benavente, R. McBride, L.A. Pearce Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis Ann Intern Med 131 1999 492 501 (Pubitemid 29482392)
7. J. Mant, F.D. Hobbs, K. Fletcher Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged study, BAFTA): a randomised controlled trial Lancet 370 2007 493 503 (Pubitemid 47212371)
8. S.J. Connolly, J. Pogue, R.G. Hart ACTIVE Investigators Effect of clopidogrel added to aspirin in patients with atrial fibrillation N Engl J Med 360 2009 2066 2078
9. CAPRIE steering committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1996 1329 1339
10. D.M. Fick, J.W. Cooper, W.E. Wade Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts Arch Intern Med 163 2003 2716 2724 (Pubitemid 37517412)
11. T.E. Lackner, G.N. Battis Use of warfarin for nonvalvular atrial fibrillation in nursing home patients Arch Fam Med 4 1995 1017 1026
12. McCormick D, Gurwitz JH, Goldberg RJ, et al. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med. 200;161:24582463.
13. V. Perera, B.V. Bajorek, S. Matthews, S.N. Hilmer The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation Age Ageing 38 2009 15662
14. B.A. Hutten, A.W. Lensing, R.A. Kraaijenhagen, M.H. Prins Safety of treatment with oral anticoagulants in the elderly A systematic review Drugs Aging 14 1999 303 312 (Pubitemid 29195346)
15. E. Pautas, I. Gouin-Thibault, M. Debray Haemorrhagic complications of vitamin K antagonists in the elderly: risk factors and management Drugs Aging 23 2006 13 25 (Pubitemid 43290881)
16. J.L. Sebastian, D.D. Tresch Use of oral anticoagulants in older patients Drugs Aging 16 2000 409 435 (Pubitemid 30420797)
17. H. Wynne, L. Cope, P. Kelly The influence of age, liver size and enantiomer concentrations on warfarin requirements Br J Clin Pharmacol 40 1995 203 207
18. F. Kamali, T.I. Khan, B.P. King Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin Clin Pharmacol Ther 75 2004 204 212 (Pubitemid 38314870)
19. J.H. Gurwitz, J. Avorn, D. Ross-Degnan Aging and the anticoagulant response to warfarin therapy Ann Intern Med 116 1992 901 904 (Pubitemid 23034781)
20. M. Redwood, C. Taylor, B.J. Bain, J.H. Matthews The association of age with dosage requirement for warfarin Age Ageing 20 1991 217 220
21. D. Garcia, S. Regan, M. Crowther Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population Chest 127 2005 2049 2056
22. H.A. Wynne, F. Kamali, C. Edwards Effect of ageing upon warfarin dose requirements: a longitudinal study Age Ageing 25 1996 429 431 (Pubitemid 26418170)
23. L.Z. Rubenstein, K.R. Josephson, A.S. Robbins Falls in the nursing home Ann Intern Med 121 1994 442 451
24. J.H. Gurwitz, T.S. Field, M.J. Radford The safety of warfarin therapy in the nursing home setting Am J Med 120 2007 539 544 (Pubitemid 46779036)
25. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators N Engl J Med 323 1990 1505 1511
26. Stroke prevention in atrial fibrillation study Final results Circulation 84 1991 527 539
27. M.D. Ezekowitz, S.L. Bridgers, K.E. James Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation Veterans Affairs stroke prevention in nonrheumatic atrial fibrillation investigators N Engl J Med 327 1992 1406 1412
28. E. Birman-Deych, M.J. Radford, D.S. Nilasena, B.F. Gage Use and effectiveness of warfarin in medicare beneficiaries with atrial fibrillation Stroke 37 2006 1070 1074
29. N. Cohen, D. Almoznino-Sarafian, I. Alon Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission Stroke 31 2000 1217 1222 (Pubitemid 30351236)
30. B.F. Gage, M. Boechler, A.L. Doggette Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation Stroke 31 2000 822 827 (Pubitemid 30198422)
31. J.H. Gurwitz, J. Monette, P.A. Rochon Atrial fibrillation and stroke prevention with warfarin in the long-term care setting Arch Intern Med 157 1997 978 984 (Pubitemid 27190885)
32. J.L. Meyers, K.L. Davis, Y.F. Yu Stroke and transient ischemic attack in the long-term care setting: patient characteristics, medication treatment, and length of stay Consult Pharm 26 2011 170 181
33. R.A. Kokotailo, M.D. Hill Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10 Stroke 36 2005 1776 1781 (Pubitemid 41098778)
34. S. Agarwal, D. Bennett, D.J. Smith Predictors of warfarin use in atrial fibrillation patients in the inpatient setting Am J Cardiovasc Drugs 10 2010 37 48
35. A.L. Waldo, R.C. Becker, V.F. Tapson, K.J. Colgan NABOR Steering Committee Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation J Am Coll Cardiol 46 2005 1729 1736 (Pubitemid 41531631)
36. V. Fuster, L.E. Rydn, R.W. Asinger American College of Cardiology/American Heart Association Task Force on Practice Guidelines European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) North American Society of Pacing and Electrophysiology ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology Circulation 104 2001 2118 2150 (Pubitemid 33028911)
37. B.F. Gage, A.D. Waterman, W. Shannon Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation JAMA 285 2001 2864 2870 (Pubitemid 32537350)
38. Coumadin (warfarin) [package insert] 2011 Bristol-Myers Squibb Princeton, NJ
39. R.J. Beyth, L.M. Quinn, C.S. Landefeld Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin Am J Med 105 1998 91 99 (Pubitemid 28405230)
40. R. Pisters, D.A. Lane, R. Nieuwlaat A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 138 2010 1093 1100
41. E. Birman-Deych, A.D. Waterman, Y. Yan Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors Med Care 43 2005 480 485 (Pubitemid 40694609)
42. C. Benesch, D.M. Witter Jr, A.L. Wilder Inaccuracy of the international classification of diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease Neurology 49 1997 660 664 (Pubitemid 27428001)
43. D.C. Angus, W.T. Linde-Zwirble, J. Lidicker Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 2001 1303 1310 (Pubitemid 32641789)
44. G.S. Martin, D.M. Mannino, S. Eaton, M. Moss The epidemiology of sepsis in the united states from 1979 through 2000 N Engl J Med 348 2003 1546 1554 (Pubitemid 36437931)
45. R. Rinaldi, L. Vignatelli, M. Galeotti Accuracy of ICD-9 codes in identifying ischemic stroke in the General Hospital of Lugo Di Romagna (Italy) Neurol Sci 24 2003 65 69 (Pubitemid 36790335)
46. S.E. Andrade, J.H. Gurwitz, K.A. Chan Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study J Clin Epidemiol 55 2002 310 313 (Pubitemid 34195528)
47. D.S. Raiford, S. Perez Gutthann, L.A. Garcia Rodriguez Positive predictive value of ICD-9 codes in the identification of cases of complicated peptic ulcer disease in the Saskatchewan Hospital automated database Epidemiology 7 1996 101 104 (Pubitemid 26003854)
48. Y. Kiyota, S. Schneeweiss, R.J. Glynn Accuracy of medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records Am Heart J 148 2004 99 104 (Pubitemid 38900487)
49. J.B. Christian, K.L. Lapane, R.S. Toppa Racial disparities in receipt of secondary stroke prevention agents among US nursing home residents Stroke 34 2003 2693 2697 (Pubitemid 37392769)
50. O. Liangos, R. Wald, J.W. O'Bell Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey Clin J Am Soc Nephrol 1 2006 43 51
51. V. Rollason, N. Vogt Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist Drugs Aging 20 2003 817 832 (Pubitemid 37159599)
52. American Geriatrics Society Clinical Practice Committee The use of oral anticoagulants (warfarin) in older people American Geriatrics Society guideline J Am Geriatr Soc 50 2002 1439 1445 discussion 14461447
53. B.C. Bradley, K.S. Perdue, K.A. Tisdel, D.M. Gilligan Frequency of anticoagulation for atrial fibrillation and reasons for its non-use at a Veterans Affairs medical center Am J Cardiol 85 2000 568 572
54. B.F. Gage, M. Boechler, A.L. Doggette Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation Stroke 31 2000 822 827 (Pubitemid 30198422)
55. L.R. Tulner, J.P. Van Campen, I.M. Kuper Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study Drugs Aging 27 2010 39 50
56. T.J. Bungard, W.A. Ghali, K.K. Teo Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 160 2000 41 46 (Pubitemid 30040971)
57. J. Monette, J.H. Gurwitz, P.A. Rochon, J. Avorn Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners J Am Geriatr Soc 45 1997 1060 1065 (Pubitemid 27377551)
58. S.J. Connolly, M.D. Ezekowitz, S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
59. J.V. Freeman, R.P. Zhu, D.K. Owens Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation Ann Intern Med 154 2011 1 11
60. M. Legrand, J. Mateo, A. Aribaud The use of dabigatran in elderly patients Arch Intern Med 171 2011 1285 1286
61. J.A. Johnston, R.J. Cluxton Jr, P.C. Heaton Predictors of warfarin use among ohio Medicaid patients with new-onset nonvalvular atrial fibrillation Arch Intern Med 163 2003 1705 1710 (Pubitemid 36898959)
62. A.S. Go, E.M. Hylek, L.H. Borowsky Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study Ann Intern Med 131 1999 927 934 (Pubitemid 30005032)
63. L. Friberg, N. Hammar, M. Ringh Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study) Eur Heart J 27 2006 1954 1964 (Pubitemid 44297370)
64. D. Poli, E. Antonucci, E. Grifoni Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years J Am Coll Cardiol 54 2009 999 1002
65. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation Analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449 1457
66. A.M. Holbrook, J.A. Pereira, R. Labiris Systematic overview of warfarin and its drug and food interactions Arch Intern Med 165 2005 1095 1106 (Pubitemid 40720733)
67. M. Verhovsek, B. Motlagh, M.A. Crowther Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review BMC Geriatr 8 2008 13
68. B.F. Gage, Y. Yan, P.E. Milligan Clinical classification schemes for predicting hemorrhage: results from the national registry of atrial fibrillation (NRAF) Am Heart J 151 2006 713 719 (Pubitemid 43290267)
69. R.J. Beyth, L.M. Quinn, C.S. Landefeld Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin Am J Med 105 1998 91 99 (Pubitemid 28405230)